An immune regulator of addiction

drugs
Credit: CC0 Public Domain

Drug addiction is often thought of as neuron-centric, but in a study published in the Proceedings of the National Academy of Sciences, M.D./Ph.D. student Daniel Kashima and his mentor, Brad Grueter, Ph.D., show that the immune system also plays a critical role.

They studied the consequence of lacking toll-like receptor 4 (TLR4) on drug-associated physiology and behavior. TLR4 is a pattern-recognition molecule of the innate immune system.

They found that TLR4 knockout mice exhibited a difference in the ability to dynamically change the strength of in the core (NAc), a key brain area that processes motivation and reward.

This was associated with a deficit in drug-reward learning. They further showed that microglia, one of the brain's , are the primary cell type that expressed TLR4.

These results suggest that TLR4 is a novel regulator of NAc neuronal physiology and associated drug-reward learning.


Explore further

Drug that could aid in vaccines activates innate immune system in novel way

More information: Daniel T. Kashima et al. Toll-like receptor 4 deficiency alters nucleus accumbens synaptic physiology and drug reward behavior, Proceedings of the National Academy of Sciences (2017). DOI: 10.1073/pnas.1705974114
Citation: An immune regulator of addiction (2017, August 7) retrieved 18 November 2019 from https://medicalxpress.com/news/2017-08-immune-addiction.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
6 shares

Feedback to editors

User comments